Buy Cardivas 12.5 mg (Carvedilol) – Proven Alpha/Beta Blocker for High Blood Pressure & Heart Failure

Cardivas 12.5 mg, manufactured by Sun Pharma, contains carvedilol—a non‑selective beta‑blocker with added alpha‑1 blockade. It’s used for hypertension, congestive heart failure (CHF), and left ventricular dysfunction following a heart attack. 

How It Works

Carvedilol blocks β‑adrenergic receptors (β₁, β₂) and α₁ receptors, reducing heart rate, lowering peripheral resistance, and improving cardiac output—beneficial for hypertension and heart failure. 

Indications & Benefits

• Treats essential hypertension when lifestyle changes are insufficient or combination therapy needed. 
• Manages chronic systolic heart failure and reduces mortality and hospitalization. 
• Used in patients with left ventricular dysfunction after a myocardial infarction. 

Dosage & Administration

• Initial dose: 12.5 mg once daily for 2 days for hypertension; may be increased to 25 mg/day or higher based on tolerance. 
• In CHF: begin at 3.125 mg twice daily, titrate every 1–2 weeks up to 25 mg twice daily (or higher by weight). 
• Take with food to reduce orthostatic hypotension; swallow tablets whole. 
• If a dose is missed, take it when remembered unless near next dose—do not double. 

Common Side Effects & Safety

• Frequent: dizziness, fatigue, low blood pressure, slow heart rate, diarrhea, weakness, weight gain, erectile dysfunction. 
• Less common: lightheadedness, nasal congestion, shortness of breath, headache. 
• Serious: worsening heart failure (especially during dose increases), bradycardia, heart block, bronchospasm in respiratory patients. 

Precautions & Interactions

• Contraindicated: asthma, decompensated heart failure, cardiogenic shock, high-grade AV block, sick sinus syndrome, severe bradycardia, severe hepatic impairment. 
• Do not discontinue abruptly—gradual tapering required to avoid rebound hypertension or angina. 
• May mask hypoglycemia symptoms in diabetics; monitor blood sugar carefully. 
• Drug interactions: increased bradycardia risk with digoxin, amiodarone, non-dihydropyridine calcium-channel blockers, ivabradine. 
• Avoid alcohol during dose initiation; monitor blood pressure when standing. 

Global Availability & Prescription Info

Cardivas 12.5 mg is a prescription-only medication manufactured in India by Sun Pharma. It’s available worldwide via licensed pharmacies and must be used under medical supervision, with regular monitoring of heart function and blood pressure. 

📌 Frequently Asked Questions (FAQs)

1. What is Cardivas 12.5 mg used for?

It is used to lower blood pressure and manage chronic heart failure or left ventricular dysfunction post-myocardial infarction. 

2. How soon will I notice effects?

Blood pressure reduction typically appears within 1–2 hours after dose. Heart failure benefit may take several weeks of consistent use. 

3. What side effects might occur?

Common side effects include tiredness, dizziness, low blood pressure, slow heart rate, and gastrointestinal issues. Serious effects include severe bradycardia, fluid retention, worsening heart failure, or breathing difficulty. 

4. Can I stop it suddenly?

No—stopping suddenly can worsen heart condition. Taper gradually under a doctor’s guidance. 

5. Are there drug/drink restrictions?

Avoid alcohol initially and when adjusting doses. Be cautious when using other heart-rate lowering drugs or antiarrhythmics. Monitor diabetes carefully and avoid abrupt posture changes to avoid fainting.